These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 308662)

  • 1. Blockade of para-methoxyamphetamine induced serotonin release by serotonin uptake inhibitors.
    Tseng LF
    Proc West Pharmacol Soc; 1978; 21():7-9. PubMed ID: 308662
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxytryptamine uptake inhibitors block para- methoxyamphetamine-induced 5-HT release.
    Tseng LF
    Br J Pharmacol; 1979 Jun; 66(2):185-90. PubMed ID: 313827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of para-methoxyamphetamine- induced serotonergic effects by chlorimipramine.
    Tseng LF; Harris RA; Loh NH
    J Pharmacol Exp Ther; 1978 Jan; 204(1):27-38. PubMed ID: 579354
    [No Abstract]   [Full Text] [Related]  

  • 4. p-Iodoamphetamine as a serotonin depletor in rats.
    Fuller RW; Snoddy HD; Snoddy AM; Hemrick SK; Wong DT; Molloy BB
    J Pharmacol Exp Ther; 1980 Jan; 212(1):115-9. PubMed ID: 6965412
    [No Abstract]   [Full Text] [Related]  

  • 5. 6-Chloro-2-aminotetralin, a rigid Conformational analog of 4-chloroamphetamine: pharmacologic properties of it and related compounds in rats.
    Fuller RW; Perry KW; Baker JC; Molloy BB
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):141-53. PubMed ID: 4455127
    [No Abstract]   [Full Text] [Related]  

  • 6. Some neuropharmacological effects of Ro 11-2465--a novel tricyclic antidepressant with potent inhibitory activity on the uptake of 5-HT.
    Da Prada M; Keller HH; Burkard WP; Schaffner R; Bonetti EP; Launay JM; Haefely W
    Adv Biochem Psychopharmacol; 1982; 31():235-48. PubMed ID: 6177199
    [No Abstract]   [Full Text] [Related]  

  • 7. The increased release of 3H-5-hydroxytryptamine by d-para-methoxyamphetamine and d-amphetamine in vivo.
    Tseng LF
    Proc West Pharmacol Soc; 1976; 19():136-41. PubMed ID: 1036622
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140).
    Fuller RW; Perry KW; Molloy BB
    Life Sci; 1974 Sep; 15(6):1161-71. PubMed ID: 4550008
    [No Abstract]   [Full Text] [Related]  

  • 9. An in vivo useful tool to evaluate the activity of serotonin uptake inhibitors: prevention by chlorimipramine of the prolactin releasing action of d-fenfluramine.
    Quattrone A; Schettini G; Di Renzo GF; Amoroso S; Annunziato L
    Adv Biochem Psychopharmacol; 1982; 31():229-34. PubMed ID: 7080898
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonism of the acute and long-term biochemical effects of 4-chloroamphetamine on the 5-HT neurones in the rat brain by inhibitors of the 5-hydroxytryptamine uptake.
    Ross SB
    Acta Pharmacol Toxicol (Copenh); 1976; 39(4):456-76. PubMed ID: 989691
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo effect of danitracen on the uptake mechanisms in monoaminergic neurons and platelets in rats.
    Wielosz M; Przegaliński E; Kieinrok Z
    Pol J Pharmacol Pharm; 1978; 30(2-3):263-8. PubMed ID: 673930
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical pharmacology of the serotonin system.
    Fuller RW
    Adv Neurol; 1986; 43():469-80. PubMed ID: 2936068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
    Schmidt CJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):1-7. PubMed ID: 2433425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CGP 6085 A, a new, specific, inhibitor of serotonin uptake: neurochemical characterization and comparison with other serotonin uptake blockers.
    Waldmeier PC; Baumann PA; Maítre L
    J Pharmacol Exp Ther; 1979 Oct; 211(1):42-9. PubMed ID: 490325
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of d-amphetamine and potassium on serotonin release and metabolism in rat cerebral cortex tissue.
    Homan HD; Ziance RJ
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):223-40. PubMed ID: 6164082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of serotonin reuptake.
    Fuller RW; Wong DT
    Fed Proc; 1977 Jul; 36(8):2154-8. PubMed ID: 326579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential antidopaminergic effects of serotonin reuptake inhibitors.
    Kim SW; Dysken MW
    J Clin Psychiatry; 1991 Jan; 52(1):42. PubMed ID: 1988420
    [No Abstract]   [Full Text] [Related]  

  • 19. p,p'-DDT-induced alterations in brain serotonin metabolism.
    Chung Hwang E; Van Woert MH
    Neurotoxicology; 1981 Dec; 2(4):649-57. PubMed ID: 6176920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism by which uptake inhibitors antagonize p-chloroamphetamine-induced depletion of brain serotonin.
    Fuller RW
    Neurochem Res; 1980 Mar; 5(3):241-5. PubMed ID: 7374882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.